Search by Drug Name or NDC

    NDC 45802-0088-01 albuterol sulfate 90 ug/1 Details

    albuterol sulfate 90 ug/1

    albuterol sulfate is a RESPIRATORY (INHALATION) AEROSOL, METERED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Padagis Israel Pharmaceuticals Ltd. The primary component is ALBUTEROL SULFATE.

    Product Information

    NDC 45802-0088
    Product ID 45802-088_39364d69-14eb-4546-9ceb-12b27d008d7f
    Associated GPIs 44201010103410
    GCN Sequence Number 028090
    GCN Sequence Number Description albuterol sulfate HFA AER AD 90 MCG INHALATION
    HIC3 B6W
    HIC3 Description BETA-ADRENERGIC AGENTS, INHALED, SHORT ACTING
    GCN 22913
    HICL Sequence Number 002073
    HICL Sequence Number Description ALBUTEROL SULFATE
    Brand/Generic Generic
    Proprietary Name albuterol sulfate
    Proprietary Name Suffix n/a
    Non-Proprietary Name albuterol sulfate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form AEROSOL, METERED
    Route RESPIRATORY (INHALATION)
    Active Ingredient Strength 90
    Active Ingredient Units ug/1
    Substance Name ALBUTEROL SULFATE
    Labeler Name Padagis Israel Pharmaceuticals Ltd
    Pharmaceutical Class Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA203760
    Listing Certified Through 2024-12-31

    Package

    NDC 45802-0088-01 (45802008801)

    NDC Package Code 45802-088-01
    Billing NDC 45802008801
    Package 1 INHALER in 1 CARTON (45802-088-01) / 200 AEROSOL, METERED in 1 INHALER
    Marketing Start Date 2020-02-26
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 2.60548
    Pricing Unit GM
    Effective Date 2024-02-21
    NDC Description ALBUTEROL HFA 90 MCG INHALER
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis